Concepedia

Kirk W. Kerr

KW

3

Publications

39

Citations

3

H-Index

2018

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Kirk W. Kerr is an author at Center for Drug Evaluation and Research specializing in pharmacotherapy, global health, and health policy.

ORCID

Top concepts

Publications per year

2018–2019

3

Publications

3

Is the priority review voucher program stimulating new drug development for tropical diseases?

Kirk W. Kerr, Thomas C. Henry, Kathleen L. Miller · PLoS neglected tropical diseases · 2018 · 18 citations · Full text

, , +16

An Analysis of Follow‐On Development in New Drug Classes, January 1986–June 2018

Michael Lanthier, Kirk W. Kerr, Kathleen L. Miller · Clinical Pharmacology & Therapeutics · 2019 · 11 citations · Full text

Effective Market Exclusivity of New Molecular Entities for Rare and Non-rare Diseases

Kirk W. Kerr, Lukas Glos · Pharmaceutical Medicine · 2019 · 10 citations

Rows per page

1–3 of 3